VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors
Clinical trial NCT01784861 · TERMINATED
Trial details
- NCT number
- NCT01784861
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-03
- Primary completion
- 2020-08-19
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.